Search Login Register

Mitoxantrone (Novantrone) Summary

Description: An anthracenedione-derived antineoplastic agent.

Also Known As: Novantrone; AHP Brand of Mitoxantrone Hydrochloride; ASTA Medica Brand of Mitoxantrone Hydrochloride; Amgen Brand of Mitoxantrone Hydrochloride; Baxter Oncology Brand of Mitoxantrone Hydrochloride Show All >>

Networked: 2328 relevant articles (292 outcomes, 715 trials/studies) for this Drug

Key Diseases for which Mitoxantrone is Relevant

  1. Breast Neoplasms (Breast Cancer) : 44 outcomes 144 studies in 470 results
  2. Acute Myeloid Leukemia (Acute Myelogenous Leukemia) : 37 outcomes 73 studies in 245 results
  3. Neoplasms (Cancer) : 30 outcomes 84 studies in 392 results
  4. Prostatic Neoplasms (Prostate Cancer) : 23 outcomes 70 studies in 148 results
  5. Lymphoma (Lymphomas) : 18 outcomes 49 studies in 123 results
Show All >>

Drugs Related to Mitoxantrone

  1. Cytarabine (Cytosar-U)
  2. Prednisone (Sone)
  3. Etoposide (VP 16)
  4. fludarabine
  5. Cyclophosphamide (Cytoxan)
  6. Doxorubicin (Adriamycin)
  7. docetaxel (Taxotere)
  8. Vincristine (Oncovin)
  9. rituximab (Mabthera)
  10. Fluorouracil (Carac)
Show All >>

Therapies Related to Mitoxantrone

  1. Drug Therapy (Chemotherapy)
  2. Combination Drug Therapy (Combination Chemotherapy)
  3. Castration
  4. Stem Cell Transplantation
  5. Transplantation (Transplant Recipients)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.